...tablets and a traditional Chinese medicine (TCM) formulation. It obtained both via its acquisition of Zhejiang Wansheng Pharmaceutical Co. Ltd....

...of Zhejiang Wansheng Pharmaceutical Co. Ltd. in 2015 (see BioCentury Extra, July 24, 2015) . Mary Romeo Bydureon Byetta 3SBio Inc. Eli Lilly and Co. Zhejiang Wansheng Pharmaceutical Co. Ltd. AstraZeneca...

...a recombinant human thrombopoietin (TPO) to treat chemotherapy-induced thrombocytopenia and idiopathic thrombocytopenic purpura (ITP). Zhejiang Wansheng Pharmaceutical Co. Ltd....

...3SBio Inc. (HKSE:1530) will acquire Zhejiang Wansheng Pharmaceutical Co. Ltd. (Hangzhou, China) for RMB528 million ($85.1 million). Zhejiang Wansheng markets...